Faculty of medicine researchers have attracted more than $21 million in funding from the Canadian Institutes of Health Research (CIHR).
In all, 354 research grants were funded for a total investment of approximately $274 million through the Project Grants: Fall 2020 competition. In addition, 97 priority announcement grants were funded to a total amount of $9,575,000 and 11 supplemental prizes were awarded for a total of $296,500.
UBC researchers attracted a total of $25.6 million for 41 projects. Thirty-three UBC-led projects received Project Grant funding totalling $24.8 million and eight UBC-led projects received priority announcement grants totalling $775,000.
Douglas Allan, department of cellular and physiological sciences
Project: Transcriptional programs of synapse maturation
CIHR Funding: $856,800 (5 years)
Ali Bashashati, School of Biomedical Engineering;Peter Black, department of urologic sciences;Larry Goldenberg, department of urologic sciences
Project: Prostate cancer risk stratification for active surveillance using computer-aided analysis of histopathology and transcriptomics
CIHR Funding: $906,525 (5 years)
Colin Collins, department of urologic sciences
Project: Uncovering early mediators of lineage plasticity and validation of a metabolic vulnerability in neuroendocrine prostate cancer
CIHR Funding: $1,147,500 (5 years)
Angela Devlin, department of pediatrics;Pascal Bernatchez,department of anesthesiology, pharmacology and therapeutics;Constadina Panagiotopoulos, department of pediatrics
Project: Correcting early vascular dysfunction to improve cardiovascular outcomes in type 1 diabetes
CIHR Funding: $841,500 (5 years)
Quynh Doan,department of pediatrics
Project: Evaluating the psychometric properties and help-seeking impact of HEARTSMAP-U: a digital psychosocial self-assessment and navigational support application for post-secondary students.
CIHR Funding: $554,624 (4 years)
Nichole Fairbrother, department of psychiatry
Project: Perinatal Anxiety Disorders Screening Study
CIHR Funding: $684,676 (4 years)
David Fedida, department of anesthesiology, pharmacology and therapeutics
Project: Mechanisms of potassium channel activator action on Kv7.1 ion channel complexes.
CIHR Funding: $971,550 (5 years)
Brian Grunau, department of emergency medicine;Jane Buxton, School of Population and Public Health;James Christenson, department of emergency medicine
Project: Opioid Overdose-Related Cardiac Arrest: What are the Best Interventions?
CIHR Funding: $283,051 (3 years)
Joerg Gsponer, department of biochemistry and molecular biology;Lawrence Mcintosh, department of biochemistry and molecular biology
Project: Protein phase separation: A new mechanism of protein function regulation in Mycobacterium tuberculosis
CIHR Funding: $887,400 (5 years)
Jaime Guzman, department of pediatrics
Project: Treating Children with Arthritis According to their Individual Probability of Outcomes and Response to Treatments The PERSON-JIA Trial
CIHR Funding: $455,175 (5 years)
Nicholas Bansback, School of Population and Public Health
Project: Evaluating the impact of a mandatory switching policy for biosimilars
CIHR Funding: $298,350 (3 years)
Rob Holt, department of medical genetics
Project: Lentiviral infusion as a universal approach for genetically modified immune effector cell therapies.
CIHR Funding: $642,600 (4 years)
Rosemin Kassam, School of Population and Public Health
Project: Women supporting women using local solutions to improve infant and young child feeding and care practices in Punjab, Pakistan
CIHR Funding: $799,425 (5 years)
Christian Kastrup, department of biochemistry and molecular biology
Project: Minimally-invasive device and bioabsorbable hemostatic powder for managing non-compressible torso hemorrhage
CIHR Funding: $455,176 (4 years)
Jayachandran Kizhakkedathu, pathology and laboratory medicine;Dirk Lange, department of urologic sciences
Project: Novel Infection Resistant Coating in an Era of Drug Resistant Bacteria for the Treatment and Prevention of Medical Device Infection
CIHR Funding: $520,199 (3 years)
Rodney Knight, department of medicine
Project: Identifying the impact of cannabis use on mental health outcomes among sexual and gender minority youth: A mixed-methods study
CIHR Funding: $478,126 (3 years)
Chinten James Lim, department of pathology and laboratory medicine
Project: Targeting CD47 in pediatric acute lymphoblastic leukemia.
CIHR Funding: $1,028,925 (5 years)
Teresa Liu-AmbroseandLinda Li, department of physical therapy
Project: SuPA Mobility: Supporting Physical Activity to Promote Mobility in Mobility-Limited Older Adults
CIHR Funding: $631,128 (6 years)
Martin Mckeown, department of medicine, division of neurology
Project: In silico Design of Precision Electrical Stimuli for Electrical Vestibular Stimulation in Parkinsons Disease.
CIHR Funding: $841,270 (5 years)
Robert Molday, department of biochemistry and molecular biology
Project: High Resolution Structure of Human ABCA4, an ATP-binding Cassette (ABC) Lipid Importer Associated with Inherited Retinal Degenerative Diseases
CIHR Funding: $918,000 (5 years)
Melanie Murray, department of medicine
Project: Role of Female Sex Hormones on Aging in Women Living with HIV.
CIHR Funding: $382,500 (5 years)
Ivan Nabi, department of cellular and physiological sciences
Project: Using super-resolution microscopy to define the role of caveolin-1 in cancer
CIHR Funding: $910,350 (5 years)
Nobuhiko Tokuriki, department of biochemistry and molecular biology
Project: Novel antibiotic therapies that target bacterial energetic systems
CIHR Funding: $956,250 (5 years)
Michael Underhill, department of cellular and physiological sciences
Project: Tissue-resident mesenchymal progenitors and aging
CIHR Funding: $971,550 (5 years)
Cheryl Wellington, department of pathology and laboratory medicine;Angela Brooks-Wilson, department of medical genetics);Ging-Yuek Robin Hsiung, department of medicine
Project: Evaluating the potential of blood biomarkers to improve Alzheimers Disease risk stratification
CIHR Funding: $1,503,224 (4 years)
Christian Steidl, department of pathology and laboratory medicine
Project: Somatic mutations in the JAK-STAT and IRF signaling pathways in Non-Hodgkin lymphoma
CIHR Funding: $1,120,725 (5 years)
Glen Tibbits, department of pathology and laboratory medicine
Project: Catecholaminergic polymorphic ventricular tachycardia (CPVT): arrhythmogenic mechanisms and personalized intervention
CIHR Funding: $924,120 (5 years)
Jan Dutz, department of dermatology and skin science
Project: Phototherapy to modulate regulatory T cells and prevent autoimmune disease
CIHR Funding: $382,499 (3 years)
Kendall Ho, department of emergency medicine
Project: Technologies for Home Medication Vigilance and Protection (TEC4Home MVP)
Priority Announcement: Health Services and Policy Research
CIHR Funding: $50,000 / Canadian Medical Association (Ottawa) Funding: $50,000
Brodie Sakakibara, department of occupational science and occupational therapy
Project: Advancing virtual care in stroke rehabilitation: TeleRehabilitation with Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL)
Priority Announcement: Health Services and Policy Research
CIHR Funding: $50,000 / Canadian Medical Association (Ottawa) Funding: $50,000
Wendy Norman, department of family practice
Project: The CART PREG-Epi Study: Pandemic Reproductive health and health Equity- Guidance from Epidemiology to improve reproductive, perinatal, and maternal mental health and substance use care
Priority Announcement: Population and Public Health Public Health Systems
CIHR Funding: $100,000
Patricia Janssen, School of Population and Public Health
- Exercise promotes a molecular profile in muscle: Research - January 21st, 2023
- Molecular Diagnostics Laboratory < Laboratory Medicine - January 4th, 2023
- Molecular cloning - Wikipedia - December 18th, 2022
- Trends in Molecular Medicine | Journal - ScienceDirect - December 10th, 2022
- Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases... - December 2nd, 2022
- Nuclear Medicine and Molecular Imaging Week: October 2-8, 2022 - October 29th, 2022
- Biochemistry & Molecular Biology | Medicine - October 29th, 2022
- Cellular and Molecular Medicine | Faculty of Medicine - October 21st, 2022
- Molecular Diagnostics > Fact Sheets > Yale Medicine - October 21st, 2022
- Expert Reviews in Molecular Medicine | Cambridge Core - October 13th, 2022
- UT Southwestern ranked top health care institution globally for published research by Nature Index - UT Southwestern - October 13th, 2022
- Common Antibiotics Are Losing Their Potency. Researchers Pinpoint Mechanism to Restore It. - NYU Langone Health - October 13th, 2022
- expert reaction to study looking at integrating human stem cell-derived brain-like tissue in the brains of newborn rats - Science Media Centre - October 13th, 2022
- HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery - Yahoo Finance - October 13th, 2022
- UVA Discovers Key Driver of High Blood Pressure - UVA Health Newsroom - October 13th, 2022
- Postdoctoral Fellow in Lung Cancer Genomics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311727 - Times Higher Education - October 13th, 2022
- Common cold may increase the risk of long Covid - Earth.com - October 13th, 2022
- Caris' Precision Oncology Alliance Welcomes The Cancer Institute at The University of Tennessee Medical Center - PR Newswire - October 13th, 2022
- Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics - Yahoo... - October 13th, 2022
- Molecular Test Could Improve Early Detection of Pancreatic Cancer - Technology Networks - October 13th, 2022
- UTSW researchers identify key player in cellular response to stress - EurekAlert - October 4th, 2022
- New Antibody Demonstrates Therapeutic Benefits Against Alzheimers - SciTechDaily - October 4th, 2022
- Mount Sinai study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention - EurekAlert - October 4th, 2022
- NovoPath Pushes the Limits of Laboratory Information Systems with Integrated Workflows for Genetic and Molecular Testing - PR Newswire - October 4th, 2022
- Postdoctoral Fellow in Bioinformatics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311073 - Times Higher Education - October 4th, 2022
- Breast Cancer Awareness | Nick Jacobs | An unlikely partnership: The United States Army Space and Missile Defense Command and the Joyce Murtha Breast... - October 4th, 2022
- Tackling resistance to HIF2 drugs with an RNA-based therapy - UT Southwestern - October 4th, 2022
- OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis - Business... - October 4th, 2022
- SIMATS organizes Induction Ceremony - Afternoonnews - Afternoon News - October 4th, 2022
- ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology - Yale School of Medicine - September 25th, 2022
- Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes - Business Wire - September 25th, 2022
- New Startups Built From UC Davis Innovations Drive Solutions in Food, Health and Agriculture - University of California, Davis - September 25th, 2022
- Scientists Discover New Cancer Treatment - The Morning News - September 25th, 2022
- Rewriting the Textbook for Precision Medicine - Technology Networks - September 25th, 2022
- Biden says 'The pandemic is over,' but health experts disagree - Chief Healthcare Executive - September 25th, 2022
- Discovery Illuminates How Parkinson's Disease Spreads in The Brain - Weill Cornell Medicine Newsroom - September 25th, 2022
- AI Used to Determine Cause of Alzheimer's and Related Disorders - Inside Precision Medicine - September 25th, 2022
- Looking Ahead in the Treatment of Breast Cancer - Targeted Oncology - September 25th, 2022
- Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children - EurekAlert - September 25th, 2022
- New study reveals breakthrough infections increase immunity to COVID-19 - OHSU News - September 25th, 2022
- Coronavirus Today: Who's dying of COVID-19 now? - Los Angeles Times - September 25th, 2022
- Hoag Named Radiopharmaceutical Therapy Center of Excellence, Publishes Results of Breast and Prostate Cancer Trials - PR Newswire - September 8th, 2022
- Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines - Yahoo Finance - September 8th, 2022
- Scientists urged the Biden administration to launch an Operation Warp Speed to develop inhaled COVID vaccines. China beat the U.S. to the punch -... - September 8th, 2022
- Foundation Medicine to Share 14 Abstracts at the 2022 European Society for Medical Oncology (ESMO) Congress Demonstrating the Power of Genomic... - September 8th, 2022
- Monte Rosa Therapeutics Announces FDA Clearance of Investigational New Drug Application for MRT-2359, a GSPT1-directed Molecular Glue Degrader Phase... - September 8th, 2022
- Biden administration says the once-a-year shot phase of the COVID-19 pandemic has arrived - The Boston Globe - September 8th, 2022
- ICCBS welcomes students of MPhil and PhD Programs 2022 - The Academia Mag - September 8th, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 308114 - Times... - September 8th, 2022
- Congratulations to our NRF award winners | UCT News - University of Cape Town News - September 8th, 2022
- Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate - EurekAlert - September 8th, 2022
- Molecular Medicine (M.Sc.) - Georg-August-Universitt Gttingen - August 30th, 2022
- Gradalis Announces Publication in Nature Communications Medicine Identifying Survival Predicting Biomarker in Patients with Ovarian Cancer Treated... - August 30th, 2022
- Feinstein Institutes Get $3M From Lupus Research Alliance to Study Remission and Future Therapies - Business Wire - August 30th, 2022
- Unlocking the Power of Precision Medicine the Rheumatology Example - Technology Networks - August 30th, 2022
- When to trust your covid test results and when to question them | Mint - Mint - August 30th, 2022
- Molecular Diagnostics Market Report 2022-2030: Increasing Adoption of Point-Of-Care (Poc) Testing and the Development of Novel Assays Presents... - August 30th, 2022
- Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic's Genomics Module - Newswise - August 30th, 2022
- Tiny, Touch-Based Sensor Could Help Patients Stay on Top of Their Medications - SciTechDaily - August 30th, 2022
- Stellar Scholars Join CLAS Faculty - UConn Today - University of Connecticut - August 30th, 2022
- COVID-19 gave new urgency to the science of restoring smell - Science News Magazine - August 30th, 2022
- Dr. Sun lab wins R01 from National Institutes of Health to study liver proteins - Wayne State University - August 22nd, 2022
- Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference - GlobeNewswire - August 22nd, 2022
- New Study Identifies How A Group Of Genes Are Linked To Behavioral Conditions - Forbes - August 22nd, 2022
- New gene variant that protects against coronary heart disease uncovered - EurekAlert - August 22nd, 2022
- How a Japanese Herbal Medicine Protects the Gut Against Inflammatory Bowel Disease - Neuroscience News - August 22nd, 2022
- Insilico Medicine presents on AI for drug discovery at 9th Annual Aging Research and Drug Discovery Conference - EurekAlert - August 22nd, 2022
- Why polio is back on the radar of Canadian health officials - Brighter World - August 22nd, 2022
- Angela DeMichele, MD, MSCE, Assesses the Value of I-SPY2 for Neoadjuvant Treatment of Early Breast Cancer - Cancer Network - August 22nd, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 304753 - Times... - August 22nd, 2022
- Sensor could help patients stay on top of their meds - EurekAlert - August 22nd, 2022
- Trivitron Healthcare launches CoE in metabolomics, genomics, newborn screening and molecular diagnostics - Express Healthcare - August 22nd, 2022
- Research Trends of Moxibustion Therapy for Pain Treatment Over the Pas | JPR - Dove Medical Press - August 22nd, 2022
- Edited Transcript of EXAI.OQ earnings conference call or presentation 18-Aug-22 12:30pm GMT - Yahoo Finance - August 22nd, 2022
- Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75 - PR Newswire - August 22nd, 2022
- Will Omicron BA.5 Be the Last of the COVID Variants? - The Epoch Times - August 22nd, 2022
- Many Paths to Failure | Harvard Medical School - Harvard Medical School - August 5th, 2022
- Mitochondrial DNA Mutations Linked to Heart Disease Risk - University of California San Diego - August 5th, 2022
- UC Davis Sets a New Record, Surpasses $1 Billion in Research Funding - University of California, Davis - August 5th, 2022
- A first update on mapping the human genetic architecture of COVID-19 - Nature.com - August 5th, 2022